ALK |
Anaplastic lymphoma kinase |
CL-R |
clindamycin-resistance |
CS |
Cigarette smoke |
CT |
Computer Tomography |
ECOG-PS |
The Eastern Cooperative Oncology Group performance status |
EGFR |
epidermal growth factor receptor |
ER-R |
erythromycin-resistant |
EUCAST |
European Committee on Antimicrobial Susceptibility Testing |
fnbA
|
fibronectin binding protein A |
GE-R |
gentamicin-resistance |
irAEs |
immune-related adverse events |
LMR |
Locus Minoris Resistentiae |
NSCLC |
non-small cell lung cancer |
PAH |
Polycyclic Aromatic Hydrocarbons |
PD |
progressive disease |
PD-1 |
Programmed death 1 |
PD-L1 |
Programmed death ligand-1 |